Pfizer CEO Albert Bourla told CNBC's Jim Cramer about his company's proposed $43 billion deal to acquire cancer drugmaker Seagen.$43 billion deal
, and Bourla said he is"optimistic" it will close by year-end or early next year. He said Pfizer is in discussion with the Federal Trade Commission to approve the deal, and that the European Commissionthat it will be able to deliver Seagen's therapy"at a scale that has not been seen before." Seagen is known for itsdue to lower-than-expected use of its Covid products like Paxlovid and the vaccine. Bourla also said the company's U.S.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCLA - 🏆 319. / 59 Read more »
Source: Investingcom - 🏆 450. / 53 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Stocks mixed into Fed meeting, new Apple MacBooks, Caterpillar and Pfizer earnings, AMD on DeckStocks mixed, Apple, Caterpillar, AMD, Pfizer
Source: startelegram - 🏆 248. / 63 Read more »